On August 26, Takeda Pharmaceutical Company and the Ministry of Health, Labour and Welfare announced that they have decided to suspend the use of certain lots (production units) of the Takeda/Moderna vaccine for COVID-19. The Ministry of Health, Labour and Welfare issued a notification regarding this matter on the same day.
The lots in question were not used at Ritsumeikan University's Kinugasa and Biwako-Kusatsu Campuses.
However, 2,600 doses of the one of the lots (lot no. 3004734) were delivered to Osaka Ibaraki Campus, and 1,520 people were vaccinated between August 20 and 25. According to the Ministry of Health, Labour and Welfare, there have been no reports of health problems related to this case.
If you have any concerns or questions about having been vaccinated with the lot in question, please contact Takeda Pharmaceutical Company at the following number.
Takeda Pharmaceutical Company Dedicated Dial for the Moderna COVID-19 Vaccine (Drug Consultation Center): 0120-793-056
Hours: 9:00 - 17:30 (excluding weekends, national holidays, and business holidays)
Office of General Affairs, The Ritsumeikan Trust